Wall Street analysts predict that AMERISAFE, Inc. (NASDAQ:AMSF) will report $92.63 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for AMERISAFE’s earnings, with estimates ranging from $92.46 million to $92.80 million. AMERISAFE posted sales of $100.03 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 7.4%. The company is expected to announce its next earnings report on Wednesday, February 28th.

On average, analysts expect that AMERISAFE will report full-year sales of $92.63 million for the current year, with estimates ranging from $373.00 million to $373.21 million. For the next financial year, analysts forecast that the company will post sales of $364.25 million per share, with estimates ranging from $364.19 million to $364.30 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for AMERISAFE.

AMERISAFE (NASDAQ:AMSF) last posted its quarterly earnings data on Wednesday, October 25th. The insurance provider reported $0.87 EPS for the quarter, beating the Zacks’ consensus estimate of $0.79 by $0.08. AMERISAFE had a net margin of 17.07% and a return on equity of 13.92%. The company had revenue of $92.90 million for the quarter, compared to analyst estimates of $92.04 million. During the same period in the prior year, the firm posted $0.93 EPS. The company’s quarterly revenue was down 5.4% on a year-over-year basis.

Several research analysts recently issued reports on AMSF shares. Zacks Investment Research raised shares of AMERISAFE from a “hold” rating to a “buy” rating and set a $65.00 target price on the stock in a research note on Monday, September 18th. Boenning Scattergood started coverage on shares of AMERISAFE in a research note on Monday, September 25th. They set a “neutral” rating on the stock. FBR & Co reissued a “buy” rating on shares of AMERISAFE in a research note on Wednesday, October 25th. SunTrust Banks reissued a “buy” rating and set a $69.00 target price on shares of AMERISAFE in a research note on Friday, October 27th. Finally, B. Riley reissued a “buy” rating on shares of AMERISAFE in a research note on Monday, November 6th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $66.00.

AMERISAFE (NASDAQ:AMSF) traded down $0.45 during trading hours on Tuesday, hitting $60.60. 114,900 shares of the stock were exchanged, compared to its average volume of 98,356. The company has a market cap of $1,180.00, a price-to-earnings ratio of 18.04 and a beta of 0.88. AMERISAFE has a 12 month low of $51.20 and a 12 month high of $69.40.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 28th. Shareholders of record on Thursday, December 14th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Wednesday, December 13th. This represents a $0.80 annualized dividend and a yield of 1.32%. AMERISAFE’s payout ratio is 23.81%.

In other AMERISAFE news, CEO G. Janelle Frost sold 1,728 shares of the company’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $66.74, for a total transaction of $115,326.72. Following the transaction, the chief executive officer now owns 54,322 shares in the company, valued at $3,625,450.28. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 2.20% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AMSF. Pinebridge Investments L.P. raised its holdings in shares of AMERISAFE by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,534 shares of the insurance provider’s stock valued at $144,000 after purchasing an additional 26 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. raised its holdings in shares of AMERISAFE by 0.9% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 11,315 shares of the insurance provider’s stock valued at $644,000 after purchasing an additional 100 shares during the last quarter. Suntrust Banks Inc. raised its holdings in shares of AMERISAFE by 5.3% in the second quarter. Suntrust Banks Inc. now owns 4,450 shares of the insurance provider’s stock valued at $252,000 after purchasing an additional 225 shares during the last quarter. Parametric Portfolio Associates LLC raised its holdings in shares of AMERISAFE by 1.6% in the second quarter. Parametric Portfolio Associates LLC now owns 23,439 shares of the insurance provider’s stock valued at $1,335,000 after purchasing an additional 374 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of AMERISAFE by 3.8% in the second quarter. The Manufacturers Life Insurance Company now owns 14,946 shares of the insurance provider’s stock valued at $851,000 after purchasing an additional 552 shares during the last quarter.

WARNING: “$92.63 Million in Sales Expected for AMERISAFE, Inc. (AMSF) This Quarter” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.americanbankingnews.com/2018/01/16/92-63-million-in-sales-expected-for-amerisafe-inc-amsf-this-quarter-2.html.

About AMERISAFE

Amerisafe, Inc is an insurance holding company. The Company is engaged in providing workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and agriculture. It is engaged in underwriting the workers’ compensation exposures inherent in these industries.

Get a free copy of the Zacks research report on AMERISAFE (AMSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AMERISAFE (NASDAQ:AMSF)

Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.